Island Pharmaceuticals Ltd（ASX: ILA）近日披露，美国食品药品监督管理局（FDA）已向公司发出通知，表示需要更多时间来最终确定对其近期提交材料的正式回复。这一进展意味着FDA对该公司提交内容的审核流程仍在进行中，但完成评估所需时间较原预期有所延长。
Island Pharmaceuticals Ltd（ASX: ILA）近日披露，美国食品药品监督管理局（FDA）已向公司发出通知，表示需要更多时间来最终确定对其近期提交材料的正式回复。这一进展意味着FDA对该公司提交内容的审核流程仍在进行中，但完成评估所需时间较原预期有所延长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.